Epineuron said FDA clearance marks a significant expansion of its portfolio. It also expands the commercial footprint of its ...

Andera Partners said today that it led a $20 million Series D financing round for urology-focused medical device maker ...

Orchestra BioMed (Nasdaq:OBIO) announced updated expectations for the timeline of its BACKBEAT cardiac pacing clinical trial.

Medtronic is reportedly planning to cease operations at its facility in Santa Rosa, California, amid reports of layoffs and ...

Orchestra BioMed (Nasdaq:OBIO) announced today that it secured $35 million in total funding through partnerships with ...

Johnson & Johnson (NYSE:JNJ) today announced results from the first clinical study of its investigational Ottava surgical ...

Stryker reported first-quarter results that missed the Wall Street analyst consensus due to a major cyberattack by ...

Johnson & Johnson (NYSE:JNJ) today shared new clinical findings from a novel U.S. pilot study of its Abiomed unit’s Impella 5 ...

Noctrix Health developed and manufactures a novel non-invasive, wearable therapy to treat drug-refractory Restless Leg ...

Neptune Medical today announced positive findings from its 50-patient, first-in-human CARE 1 study of its Triton robotic ...

MassDevice has taken its annual roundup of the largest orthopedic device companies a step further this year. Download our ...

Solventum (NYSE:SOLV) today posted first-quarter financial results that came in ahead of the consensus Wall Street forecast.